UAVenture Capital and DVI Equity Partners today announced that two of their portfolio companies, UArizona startup Freefall Aerospace and ED2, have come together to create Freefall 5G, a new company focused on capitalizing on the explosive growth of the 5G market.
Ryan Ott, undergraduate student in MIS at the Eller College of Management, joined TLA as a Student Entrepreneurial Fellow to explore opportunities in bringing technology-based solutions to the world through commercialization.
Meet Scott Glogowski, one of four Student Entrepreneurial Fellows who were brought on earlier this year to help Tech Launch Arizona (TLA) further its effort in commercializing technologies.
Startup CMLaser Technologies, Inc., has licensed a technology developed in the James C. Wyant College of Optical Sciences that will have direct applications to increase safety for military and non-military aircraft.
With the help of his Mentor-in-Residence, Steven Fernandez has been hard at work ensuring that key commercialization efforts remain active despite the organization's recent transition to remote operations.
To both alleviate patient suffering and protect healthcare workers from infection amid the COVID-19 crisis, UArizona inventors have worked with Tucson entrepreneurs to launch a startup and commercialize a new respiratory assist device that addresses both issues.
In response to the coronavirus COVID-19 outbreak, innovative librarians who developed a new online instructional system are giving it away until the end of Spring Semester to support positive learning experiences.
Through its newly developed Student Entrepreneurial Fellowship Program, TLA is providing four qualified candidates from diverse backgrounds the opportunity to work with and impact the success of high-tech startups.
What's the next step for your UArizona invention? Tech Launch Arizona’s Asset Development Program provides financial support to move world-changing ideas into the commercial sphere.
Invented by Arun Dhar of the UArizona Aquaculture Pathology Lab at the College of Agriculture & Life Sciences, the anti-viral treatment for a common, lethal infection is poised to address a $1 billion dollar shrimp industry problem.